Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 in healthy subjects
NCT02536209Phase 1Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Aug 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of elismetrep (4 arms), sponsored by Mitsubishi Tanabe Pharma. Primary endpoint: Visual Analogue Scale for Cold Pressor Test at 10 hours. Started Aug 2015; status: completed.
02
Drugs
elismetrep
Beyond the preview
Go deeper on NCT02536209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536209.